Filing Details
- Accession Number:
- 0001209191-21-026435
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-13 16:15:51
- Reporting Period:
- 2021-04-09
- Accepted Time:
- 2021-04-13 16:15:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1808865 | Iteos Therapeutics Inc. | ITOS | () | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1729505 | Mpm Bioventures 2018, L.p. | C/O Mpm Capital 450 Kendall Street Cambridge MA 02142 | No | No | Yes | No | |
| 1818701 | Mpm Bioventures 2018 Gp Llc | C/O Mpm Capital 450 Kendall Street Cambridge MA 02142 | No | No | Yes | No | |
| 1818702 | Mpm Bioventures 2018 Llc | C/O Mpm Capital 450 Kendall Street Cambridge MA 02142 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-04-09 | 119 | $29.99 | 3,665,787 | No | 4 | S | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See Footnote |
Footnotes
- Transaction effected pursuant to a plan established pursuant to Rule 10b5-1.
- The shares were sold as follows: 71 by MPM BioVentures 2014, L.P. ("BV 2014"), 2 by MPM Asset Management Investors BV2014 LLC ("AM BV2014"), 45 by MPM BioVentures 2018, L.P. ("BV 2018") and 1 by MPM Asset Management Investors BV2018 LLC ("AM BV2018"). MPM BioVentures 2014 GP LLC and MPM BioVentures 2014 LLC ("BV 2014 LLC") are the direct and indirect general partners of BV 2014 and BV 2014(B). BV 2014 LLC is the manager of AM BV2014. MPM BioVentures 2018 GP LLC and MPM BioVentures 2018 LLC ("BV 2018 LLC") are the direct and indirect general partners of BV 2018 and BV 2018(B). BV 2018 LLC is the manager of AM BV2018. Messrs. Evnin and Foley are managing directors of BV 2014 LLC and BV 2018 LLC.
- The shares are held as follows: 2,068,870 by BV 2014, 128,561 by MPM BioVentures 2014(B), L.P. ("BV 2014(B)"), 71,210 by AM BV2014, 1,306,654 by BV 2018, 64,705 by MPM BioVentures 2018(B), L.P. ("BV 2018(B)") and 25,787 by AM BV2018. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
Billionaire Hedge Funds
